General & Plastic Surgery Devices - Australia & Oceania

  • Australia & Oceania
  • The General & Plastic Surgery Devices market market in Australia & Oceania is anticipated to achieve a revenue of US$0.42bn in 2024.
  • Looking ahead, the market is expected to display a compound annual growth rate (CAGR 2024-2029) of 6.67%, resulting in a market volume of US$0.58bn by 2029.
  • When compared to other countries globally, the United States is projected to generate the highest revenue, reaching US$9,844.00m in 2024.
  • The demand for general and plastic surgery devices in Australia & Oceania is steadily increasing due to the growing population and rising disposable income.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The General & Plastic Surgery Devices market in Australia & Oceania is experiencing steady growth due to increasing customer preferences for cosmetic procedures, advancements in technology, and the region's unique local special circumstances. Customer preferences in Australia & Oceania are driving the demand for General & Plastic Surgery Devices. With a growing emphasis on physical appearance and beauty, more individuals are seeking cosmetic procedures to enhance their features or reverse the signs of aging. This trend is particularly prominent among the younger population who are more open to exploring non-invasive or minimally invasive procedures. Additionally, the rise of social media and the influence of celebrity culture have also contributed to the popularity of cosmetic procedures, as individuals strive to achieve the same flawless looks as their idols. Trends in the General & Plastic Surgery Devices market in Australia & Oceania are aligned with global developments. Technological advancements have revolutionized the field of plastic surgery, making procedures safer, more effective, and less invasive. The introduction of innovative devices such as laser-assisted liposuction machines, 3D imaging systems, and robotic surgical systems have significantly enhanced surgical outcomes and patient satisfaction. Furthermore, the growing demand for non-surgical procedures such as Botox injections, dermal fillers, and laser treatments has also fueled the market growth. These procedures offer quick results with minimal downtime, making them attractive options for individuals seeking cosmetic enhancements. Local special circumstances in Australia & Oceania contribute to the development of the General & Plastic Surgery Devices market. The region has a high standard of living and a relatively affluent population, which enables individuals to invest in cosmetic procedures. Additionally, Australia & Oceania has a strong healthcare system and a well-regulated medical industry, ensuring that patients receive high-quality care and treatment. The region also benefits from a skilled workforce of plastic surgeons and cosmetic practitioners who are trained in the latest techniques and technologies. Underlying macroeconomic factors also play a role in the growth of the General & Plastic Surgery Devices market in Australia & Oceania. Economic stability and disposable income levels influence individuals' ability to afford cosmetic procedures. As the economy grows and disposable incomes rise, more people are willing to invest in aesthetic treatments. Moreover, medical tourism is becoming increasingly popular in the region, with individuals from neighboring countries seeking cosmetic procedures in Australia & Oceania due to the region's reputation for high-quality healthcare. In conclusion, the General & Plastic Surgery Devices market in Australia & Oceania is thriving due to customer preferences for cosmetic procedures, advancements in technology, local special circumstances, and underlying macroeconomic factors. As the demand for aesthetic treatments continues to rise, the market is expected to witness further growth in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)